The central role of myostatin in skeletal muscle and whole body homeostasis

Acta Physiologica

Volumn 205, Issue 3, 2012, Pages 324-340

  Elliott, B ^a   Renshaw, D ^a   Getting, S ^a   Mackenzie, R ^a  

^a UNIVERSITY OF WESTMINSTER   (United Kingdom)

Author keywords

Adipogenesis; Cachexia; Cardiomyocyte homeostasis; Glycolysis; Muscle atrophy

Indexed keywords

FENOFIBRATE; FOLLISTATIN; MONOCLONAL ANTIBODY; MYOSTATIN; MYOSTATIN INHIBITOR; PENTOXIFYLLINE; PROTEASOME; PROTEIN INHIBITOR; PROTEIN KINASE B; SMALL INTERFERING RNA; SOMATOMEDIN; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UBIQUITIN; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOSE TISSUE; CACHEXIA; CARBOXY TERMINAL SEQUENCE; CELL PROLIFERATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DOWN REGULATION; DRUG TARGETING; GENE EXPRESSION; GLUCOSE METABOLISM; HEART MUSCLE CELL; HOMEOSTASIS; HUMAN; INFLAMMATION; MUSCLE ATROPHY; MYOBLAST; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; REVIEW; SATELLITE CELL; SKELETAL MUSCLE; SPACE FLIGHT;

ANIMALS; HOMEOSTASIS; HUMANS; MUSCLE, SKELETAL; MYOSTATIN; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTO-ONCOGENE PROTEINS C-AKT; SATELLITE CELLS, SKELETAL MUSCLE; SIGNAL TRANSDUCTION;

EID: 84861231616     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/j.1748-1716.2012.02423.x     Document Type: Review

References (141)

1. Allen, D.L. & Unterman, T.G. 2007. Regulation of myostatin expression and myoblast differentiation by FoxO and SMAD transcription factors. Am J Physiol Cell Physiol 292, C188-C199.
2. Allen, D.L., Hittel, D.S. & McPherron, A.C. 2011. Expression and function of myostatin in obesity, diabetes, and exercise adaptation. Med Sci Sports Exerc 43, 1828-1835.
3. Amirouche, A., Durieux, A.C., Banzet, S., Koulmann, N., Bonnefoy, R., Mouret, C., Bigard, X., Peinnequin, A. & Freyssenet, D. 2009. Down-regulation of Akt/mammalian target of rapamycin signaling pathway in response to myostatin overexpression in skeletal muscle. Endocrinology 150, 286-294.
4. Amthor, H., Otto, A., Vulin, A., Rochat, A., Dumonceaux, J., Garcia, L., Mouisel, E., Hourdé, C., Macharia, R., Friedrichs, M., Relaix, F., Zammit, P.S., Matsakas, A., Patel, K. & Partridge, T. 2009. Muscle hypertrophy driven by myostatin blockade does not require stem/precursor-cell activity. Proc Nat Acad Sci 106, 7479-7484.
5. Anker, S.D., Ponikowski, P., Varney, S., Chua, T.P., Clark, A.L., Webb-Peploe, K.M., Harrington, D., Kox, W.J., Poole-Wilson, P.A. & Coats, A.J. 1997. Wasting as independent risk factor for mortality in chronic heart failure. Lancet 349, 1050-1053.
6. Artaza, J.N., Bhasin, S., Mallidis, C., Taylor, W., Ma, K. & Gonzalez-Cadavid, N.F. 2002. Endogenous expression and localization of myostatin and its relation to myosin heavy chain distribution in C2C12 skeletal muscle cells. J Cell Physiol 190, 170-179.
7. Artaza, J.N., Reisz-Porszasz, S., Dow, J.S., Kloner, R.A., Tsao, J., Bhasin, S. & Gonzalez-Cadavid, N.F. 2007. Alterations in myostatin expression are associated with changes in cardiac left ventricular mass but not ejection fraction in the mouse. J Endocrinol 194, 63-76.
8. Bakker, N., Wackerhage, H. & Guttridge, D. 2005. Myostatin and NF-kappaB regulate skeletal myogenesis through distinct signaling pathways. Signal Transduction 5, 202-210.
9. Bernard, S., Leblanc, P., Whittom, F., Carrier, G., Jobin, J., Belleau, R. & Maltais, F. 1998. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 158, 629-634.
10. Biga, P.R., Cain, K.D., Hardy, R.W., Schelling, G.T., Overturf, K., Roberts, S.B., Goetz, F.W. & Ott, T.L. 2004. Growth hormone differentially regulates muscle myostatin1 and -2 and increases circulating cortisol in rainbow trout (Oncorhynchus mykiss). Gen Comp Endocrinol 138, 32-41.
11. Bish, L.T., Morine, K.J., Sleeper, M.M. & Sweeney, H.L. 2010. Myostatin is upregulated following stress in an Erk-dependent manner and negatively regulates cardiomyocyte growth in culture and in a mouse model. PLoS ONE 5, e10230.
12. Bodell, P.W., Kodesh, E., Haddad, F., Zaldivar, F.P., Cooper, D.M. & Adams, G.R. 2009. Skeletal muscle growth in young rats is inhibited by chronic exposure to IL-6 but preserved by concurrent voluntary endurance exercise. J Appl Physiol 106, 443-453.
13. Bodine, S.C., Latres, E., Baumhueter, S., Lai, V.K., Nunez, L., Clarke, B.A., Poueymirou, W.T., Panaro, F.J., Na, E., Dharmarajan, K. et al. 2001. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294, 1704-1708.
14. Bogdanovich, S., Krag, T.O., Barton, E.R., Morris, L.D., Whittemore, L.A., Ahima, R.S. & Khurana, T.S. 2002. Functional improvement of dystrophic muscle by myostatin blockade. Nature 420, 418-421.
15. Burgess, K., Xu, T., Brown, R., Han, B. & Welle, S. 2011. Effect of myostatin depletion on weight gain, hyperglycemia, and hepatic steatosis during five months of high-fat feeding in mice. PLoS ONE 6, e17090.
16. Cai, D., Frantz, J.D., Tawa, N.E. Jr, Melendez, P.A., Oh, B.C., Lidov, H.G., Hasselgren, P.O., Frontera, W.R., Lee, J., Glas, D.J. & Shoelson, S.E. 2004. IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell 119, 285-298.
17. Castillero, E., Nieto-Bona, M.P., Fernandez-Galaz, C., Martin, A.I., Lopez-Menduina, M., Granado, M., Villanua, M.A. & Lopez-Calderon, A. 2011. Fenofibrate, a PPAR alpha agonist, decreases atrogenes and myostatin expression and improves arthritis-induced skeletal muscle atrophy. Am J Physiol Endocrinol Metab 300, E790-E799.
18. Chen, Y.W., Gregory, C.M., Scarborough, M.T., Shi, R., Walter, G.A. & Vandenborne, K. 2007. Transcriptional pathways associated with skeletal muscle disuse atrophy in humans. Physiol Genomics 31, 510-520.
19. Chen, Y., Ye, J., Cao, L., Zhang, Y., Xia, W. & Zhu, D. 2010. Myostatin regulates glucose metabolism via the AMP-activated protein kinase pathway in skeletal muscle cells. Int J Biochem Cell Biol 42, 2072-2081.
20. Coffey, V.G., Shield, A., Canny, B.J., Carey, K.A., Cameron-Smith, D. & Hawley, J.A. 2006. Interaction of contractile activity and training history on mRNA abundance in skeletal muscle from trained athletes. Am J Physiol Endocrinol Metab 290, E849-E855.
21. Costelli, P., Carbo, N., Tessitore, L., Bagby, G.J., Lopez-Soriano, F.J., Argiles, J.M. & Baccino, F.M. 1993. Tumor necrosis factor-alpha mediates changes in tissue protein turnover in a rat cancer cachexia model. J Clin Invest 92, 2783-2789.
22. Costelli, P., Muscaritoli, M., Bonetto, A., Penna, F., Reffo, P., Bossola, M., Bonelli, G., Doglietto, G.B., Baccino, F.M. & Fanelli, F.R. 2008. Muscle myostatin signalling is enhanced in experimental cancer cachexia. Eur J Clin Invest 38, 531-538.
23. Dasarathy, S., Dodig, M., Muc, S.M., Kalhan, S.C. & McCullough, A.J. 2004. Skeletal muscle atrophy is associated with an increased expression of myostatin and impaired satellite cell function in the portacaval anastamosis rat. Am J Physiol Gastrointest Liver Physiol 287, G1124-G1130.
24. Escobar, J., Van Alstine, W.G., Baker, D.H. & Johnson, R.W. 2004. Decreased protein accretion in pigs with viral and bacterial pneumonia is associated with increased myostatin expression in muscle. J Nutr 134, 3047-3053.
25. Feldman, B.J., Streeper, R.S., Farese, R.V. Jr & Yamamoto, K.R. 2006. Myostatin modulates adipogenesis to generate adipocytes with favorable metabolic effects. Proc Natl Acad Sci U S A 103, 15675-15680.
26. Fernandez-Celemin, L., Pasko, N., Blomart, V. & Thissen, J.P. 2002. Inhibition of muscle insulin-like growth factor I expression by tumor necrosis factor-alpha. Am J Physiol Endocrinol Metab 283, E1279-E1290.
27. Franckhauser, S., Elias, I., Rotter Sopasakis, V., Ferre, T., Nagaev, I., Andersson, C.X., Agudo, J., Ruberte, J., Bosch, F. & Smith, U. 2008. Overexpression of Il6 leads to hyperinsulinaemia, liver inflammation and reduced body weight in mice. Diabetologia 51, 1306-1316.
28. Frost, R.A. & Lang, C.H. 2005. Skeletal muscle cytokines: regulation by pathogen-associated molecules and catabolic hormones. Curr Opin Clin Nutr Metab Care 8, 255-263.
29. Frost, R.A. & Lang, C.H. 2007. Protein kinase B/Akt: a nexus of growth factor and cytokine signaling in determining muscle mass. J Appl Physiol 103, 378-387.
30. Gentry, B.A., Ferreira, J.A., Phillips, C.L. & Brown, M. 2010. Hindlimb skeletal muscle function in myostatin-deficient mice. Muscle Nerve 43, 49-57.
31. George, I., Bish, L.T., Kamalakkannan, G., Petrilli, C.M., Oz, M.C., Naka, Y., Sweeney, H.L. & Maybaum, S. 2010. Myostatin activation in patients with advanced heart failure and after mechanical unloading. Eur J Heart Fail 12, 444-453.
32. Goncalves, M.D., Pistilli, E.E., Balduzzi, A., Birnbaum, M.J., Lachey, J., Khurana, T.S. & Ahima, R.S. 2010. Akt deficiency attenuates muscle size and function but not the response to ActRIIB inhibition. PLoS ONE 5, e12707.
33. Gonzalez-Cadavid, N.F. & Bhasin, S. 2004. Role of myostatin in metabolism. Curr Opin Clin Nutr Metab Care 7, 451-457.
34. Gonzalez-Cadavid, N.F., Taylor, W.E., Yarasheski, K., Sinha-Hikim, I., Ma, K., Ezzat, S., Shen, R., Lalani, R., Asa, S., Mamita, M., Nair, G., Arver, S. & Bhasin, S. 1998. Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting. Proc Natl Acad Sci U S A 95, 14938-14943.
35. Gonzalez-Freire, M., Santiago, C., Gomez-Gallego, F., Perez, M., Foster, C., Arenas, J. & Lucia, A. 2009. Does the K153R variant of the myostatin gene influence the clinical presentation of women with McArdle disease? Neuromuscul Disord 19, 220-222.
36. Grobet, L., Martin, L.J., Poncelet, D., Pirottin, D., Brouwers, B., Riquet, J., Schoeberlein, A., Dunner, S., Menissier, F., Massabanda, J., Fries, R., Hanset, R. & Georges, M. 1997. A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle. Nat Genet 17, 71-74.
37. Gruson, D., Ahn, S.A., Ketelslegers, J.M. & Rousseau, M.F. 2011. Increased plasma myostatin in heart failure. Eur J Heart Fail 13, 734-736.
38. Guo, T., Jou, W., Chanturiya, T., Portas, J., Gavrilova, O. & McPherron, A.C. 2009. Myostatin inhibition in muscle, but not adipose tissue, decreases fat mass and improves insulin sensitivity. PLoS ONE 4, e4937.
39. Guttridge, D.C., Mayo, M.W., Madrid, L.V., Wang, C.Y. & Baldwin, A.S. Jr 2000. NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science 289, 2363-2366.
40. Hayot, M., Rodriguez, J., Vernus, B., Carnac, G., Jean, E., Allen, D., Goret, L., Obert, P., Candau, R. & Bonnieu, A. 2010. Myostatin up-regulation is associated with the skeletal muscle response to hypoxic stimuli. Mol Cell Endocrinol 25, 431-440.
41. Heinemeier, K.M., Olesen, J.L., Schjerling, P., Haddad, F., Langberg, H., Baldwin, K.M. & Kjaer, M. 2007. Short-term strength training and the expression of myostatin and IGF-I isoforms in rat muscle and tendon: differential effects of specific contraction types. J Appl Physiol 102, 573-581.
42. Hill, J.J., Davies, M.V., Pearson, A.A., Wang, J.H., Hewick, R.M., Wolfman, N.M. & Qiu, Y. 2002. The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum. J Biol Chem 277, 40735-40741.
43. Hill, J.J., Qiu, Y., Hewick, R.M. & Wolfman, N.M. 2003. Regulation of myostatin in vivo by growth and differentiation factor-associated serum protein-1: a novel protein with protease inhibitor and follistatin domains. Mol Endocrinol 17, 1144-1154.
44. Hirai, S., Matsumoto, H., Hino, N., Kawachi, H., Matsui, T. & Yano, H. 2007. Myostatin inhibits differentiation of bovine preadipocyte. Domest Anim Endocrinol 32, 1-14.
45. Hittel, D.S., Axelson, M., Sarna, N., Shearer, J., Huffman, K.M. & Kraus, W.E. 2010. Myostatin decreases with aerobic exercise and associates with insulin resistance. Med Sci Sports Exerc 42, 2023-2029.
46. Hosoyama, T., Tachi, C., Yamanouchi, K. & Nishihara, M. 2005. Long term adrenal insufficiency induces skeletal muscle atrophy and increases the serum levels of active form myostatin in rat serum. Zoolog Sci 22, 229-236.
47. Hulmi, J.J., Ahtiainen, J.P., Kaasalainen, T., Pollanen, E., Hakkinen, K., Alen, M., Selanne, H., Kovanen, V. & Mero, A.A. 2007. Postexercise myostatin and activin IIb mRNA levels: effects of strength training. Med Sci Sports Exerc 39, 289-297.
48. Jeanplong, F., Bass, J.J., Smith, H.K., Kirk, S.P., Kambadur, R., Sharma, M. & Oldham, J.M. 2003. Prolonged underfeeding of sheep increases myostatin and myogenic regulatory factor Myf-5 in skeletal muscle while IGF-I and myogenin are repressed. J Endocrinol 176, 425-437.
49. Ji, S., Losinski, R.L., Cornelius, S.G., Frank, G.R., Willis, G.M., Gerrard, D.E., Depreux, F.F. & Spurlock, M.E. 1998. Myostatin expression in porcine tissues: tissue specificity and developmental and postnatal regulation. Am J Physiol 275, R1265-R1273.
50. Jiang, M.S., Liang, L.F., Wang, S., Ratovitski, T., Holmstrom, J., Barker, C. & Stotish, R. 2004. Characterization and identification of the inhibitory domain of GDF-8 propeptide. Biochem Biophys Res Commun 315, 525-531.
51. Jones, S.W., Hill, R.J., Krasney, P.A., O'Conner, B., Peirce, N. & Greenhaff, P.L. 2004. Disuse atrophy and exercise rehabilitation in humans profoundly affects the expression of genes associated with the regulation of skeletal muscle mass. Faseb J 18, 1025-1027.
52. Kambadur, R., Sharma, M., Smith, T.P. & Bass, J.J. 1997. Mutations in myostatin (GDF8) in double-muscled Belgian Blue and Piedmontese cattle. Genome Res 7, 910-916.
53. Kinouchi, N., Ohsawa, Y., Ishimaru, N., Ohuchi, H., Sunada, Y., Hayashi, Y., Tanimoto, Y., Moriyama, K. & Noji, S. 2008. Atelocollagen-mediated local and systemic applications of myostatin-targeting siRNA increase skeletal muscle mass. Gene Ther 15, 1126-1130.
54. Kirk, S., Oldham, J., Kambadur, R., Sharma, M., Dobbie, P. & BASS, J. 2000. Myostatin regulation during skeletal muscle regeneration. J Cell Physiol 184, 356-363.
55. Kopple, J.D., Cohen, A.H., Wang, H., Qing, D., Tang, Z., Fournier, M., Lewis, M., Casaburi, R. & Storer, T. 2006. Effect of exercise on mRNA levels for growth factors in skeletal muscle of hemodialysis patients. J Ren Nutr 16, 312-324.
56. Kraemer, W.J., Adams, K., Cafarelli, E., Dudley, G.A., Dooly, C., Feigenbaum, M.S., Fleck, S.J., Franklin, B., Fry, A.C., Hoffman, J.R., Newton, R.U., Potteiger, J., Stone, M.H., Ratamess, N.A. & Triplett-McBride, T. 2002. American college of sports medicine position stand. Progression models in resistance training for healthy adults. Med Sci Sports Exerc 34, 364-380.
57. Lang, C.H. & Frost, R.A. 2007. Sepsis-induced suppression of skeletal muscle translation initiation mediated by tumor necrosis factor alpha. Metabolism 56, 49-57.
58. Lang, C.H., Silvis, C., Nystrom, G. & FROST, R.A. 2001. Regulation of myostatin by glucocorticoids after thermal injury. Faseb J 15, 1807-1809.
59. Lang, C.H., Krawiec, B.J., Huber, D., McCoy, J.M. & Frost, R.A. 2006. Sepsis and inflammatory insults downregulate IGFBP-5, but not IGFBP-4, in skeletal muscle via a TNF-dependent mechanism. Am J Physiol Regul Integr Comp Physiol 290, R963-R972.
60. Langen, R.C., Schols, A.M., Kelders, M.C., Wouters, E.F. & Janssen-Heininger, Y.M. 2001. Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-kappaB. Faseb J 15, 1169-1180.
61. Langen, R.C., Van Der Velden, J.L., Schols, A.M., Kelders, M.C., Wouters, E.F. & Janssen-Heininger, Y.M. 2004. Tumor necrosis factor-alpha inhibits myogenic differentiation through MyoD protein destabilization. Faseb J 18, 227-237.
62. Langley, B., Thomas, M., Bishop, A., Sharma, M., Gilmour, S. & Kambadur, R. 2002. Myostatin inhibits myoblast differentiation by down-regulating MyoD expression. J Biol Chem 277, 49831-49840.
63. Larsen, A.E., Tunstall, R.J., Carey, K.A., Nicholas, G., Kambadur, R., Crowe, T.C. & Cameron-Smith, D. 2006. Actions of short-term fasting on human skeletal muscle myogenic and atrogenic gene expression. Ann Nutr Metab 50, 476-481.
64. Larsen, A.E., Cameron-Smith, D. & Crowe, T.C. 2008. Conjugated linoleic acid suppresses myogenic gene expression in a model of human muscle cell inflammation. J Nutr 138, 12-16.
65. Lawlor, M.W., Read, B.P., Edelstein, R., Yang, N., Pierson, C.R., Stein, M.J., Wermer-Colan, A., Buj-Bello, A., Lachey, J.L., Seehra, J.S. & Beggs, A.H. 2011. Inhibition of activin receptor type IIB increases strength and lifespan in myotubularin-deficient mice. Am J Pathol 178, 784-793.
66. Lee, S.J. 2007. Quadrupling muscle mass in mice by targeting TGF-beta signaling pathways. PLoS ONE 2, e789.
67. Leger, B., Derave, W., De Bock, K., Hespel, P. & Russell, A.P. 2008. Human sarcopenia reveals an increase in SOCS-3 and myostatin and a reduced efficiency of Akt phosphorylation. Rejuvenation Res 11, 163-175B.
68. Lehti, T.M., Silvennoinen, M., Kivelä, R., Kainulainen, H. & Komulainen, J. 2007. Effects of streptozotocin-induced diabetes and physical training on gene expression of titin-based stretch-sensing complexes in mouse striated muscle. Am J Physiol Endocrinol Metab 292, E533-E542.
69. Li, Y.P. & Reid, M.B. 2000. NF-kappaB mediates the protein loss induced by TNF-alpha in differentiated skeletal muscle myotubes. Am J Physiol Regul Integr Comp Physiol 279, R1165-R1170.
70. Li, Y.P. & Schwartz, R.J. 2001. TNF-alpha regulates early differentiation of C2C12 myoblasts in an autocrine fashion. Faseb J 15, 1413-1415.
71. Li, Y.P., Chen, Y., John, J., Moylan, J., Jin, B., Mann, D.L. & Reid, M.B. 2005. TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle. Faseb J 19, 362-370.
72. Lin, J., Arnold, H.B., Della-Fera, M.A., Azain, M.J., Hartzell, D.L. & Baile, C.A. 2002. Myostatin knockout in mice increases myogenesis and decreases adipogenesis. Biochem Biophys Res Commun 291, 701-706.
73. Liu, W., Thomas, S.G., Asa, S.L., Gonzalez-Cadavid, N., Bhasin, S. & Ezzat, S. 2003. Myostatin is a skeletal muscle target of growth hormone anabolic action. J Clin Endocrinol Metab 88, 5490-5496.
74. Liu, C.M., Yang, Z., Liu, C.W., Wang, R., Tien, P., Dale, R. & Sun, L.Q. 2008. Myostatin antisense RNA-mediated muscle growth in normal and cancer cachexia mice. Gene Ther 15, 155-160.
75. Llovera, M., Garcia-Martinez, C., Lopez-Soriano, J., Carbo, N., Agell, N., Lopez-Soriano, F.J. & Argiles, J.M. 1998. Role of TNF receptor 1 in protein turnover during cancer cachexia using gene knockout mice. Mol Cell Endocrinol 142, 183-189.
76. Lyons, J.A., Haring, J.S. & Biga, P.R. 2010. Myostatin expression, lymphocyte population, and potential cytokine production correlate with predisposition to high-fat diet induced obesity in mice. PLoS ONE 5, e12928.
77. Ma, K., Mallidis, C., Artaza, J., Taylor, W., Gonzalez-Cadavid, N. & Bhasin, S. 2001. Characterization of 5'-regulatory region of human myostatin gene: regulation by dexamethasone in vitro. Am J Physiol Endocrinol Metab 281, E1128-E1136.
78. Manini, T.M., Vincent, K.R., Leeuwenburgh, C.L., Lees, H.A., Kavazis, A.N., Borst, S.E. & Clark, B.C. 2011. Myogenic and proteolytic mRNA expression following blood flow restricted exercise. Acta Physiol 201, 255-263.
79. Marcell, T.J., Harman, S.M., Urban, R.J., Metz, D.D., Rodgers, B.D. & Blackman, M.R. 2001. Comparison of GH, IGF-I, and testosterone with mRNA of receptors and myostatin in skeletal muscle in older men. Am J Physiol Endocrinol Metab 281, E1159-E1164.
80. Mascher, H., Tannerstedt, J., Brink-Elfegoun, T., Ekblom, B., Gustafsson, T. & Blomstrand, E. 2008. Repeated resistance exercise training induces different changes in mRNA expression of MAFbx and MuRF-1 in human skeletal muscle. Am J Physiol Endocrinol Metab 294, E43-E51.
81. Matsakas, A., Bozzo, C., Cacciani, N., Caliaro, F., Reggiani, C., Mascarello, F. & Patruno, M. 2006. Effect of swimming on myostatin expression in white and red gastrocnemius muscle and in cardiac muscle of rats. Exp Physiol 91, 983-994.
82. Matsakas, A., Mouisel, E., Amthor, H. & Patel, K. 2010. Myostatin knockout mice increase oxidative muscle phenotype as an adaptive response to exercise. J Muscle Res Cell Motil 31, 111-125.
83. Matzuk, M.M., Lu, N., Vogel, H., Sellheyer, K., Roop, D.R. & Bradley, A. 1995. Multiple defects and perinatal death in mice deficient in follistatin. Nature 374, 360-363.
84. McFarlane, C., Plummer, E., Thomas, M., Hennebry, A., Ashby, M., Ling, N., Smith, H., Sharma, M. & Kambadur, R. 2006. Myostatin induces cachexia by activating the ubiquitin proteolytic system through an NF-kappaB-independent, FoxO1-dependent mechanism. J Cell Physiol 209, 501-514.
85. McFarlane, C., Hennebry, A., Thomas, M., Plummer, E., Ling, N., Sharma, M. & Kambadur, R. 2008. Myostatin signals through Pax7 to regulate satellite cell self-renewal. Exp Cell Res 314, 317-329.
86. McMahon, C.D., Popovic, L., Jeanplong, F., Oldham, J.M., Kirk, S.P., Osepchook, C.C., Wong, K.W., Sharma, M., Kambadur, R. & Bass, J.J. 2003a. Sexual dimorphism is associated with decreased expression of processed myostatin in males. Am J Physiol Endocrinol Metab 284, E377-E381.
87. McMahon, C.D., Popovic, L., Oldham, J.M., Jeanplong, F., Smith, H.K., Kambadour, R., Sharma, M., Maxwell, L. & Bass, J.J. 2003b. Myostatin-deficient mice lose more skeletal muscle mass than wild-type controls during hindlimb suspension. Am J Physiol Endocrinol Metab 285, E82-E87.
88. McPherron, A.C. & Lee, S.J. 1997. Double muscling in cattle due to mutations in the myostatin gene. Proc Natl Acad Sci U S A 94, 12457-12461.
89. McPherron, A.C. & Lee, S.J. 2002. Suppression of body fat accumulation in myostatin-deficient mice. J Clin Invest 109, 595-601.
90. McPherron, A.C., Lawler, A.M. & Lee, S.J. 1997. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 387, 83-90.
91. Megeney, L.A., Kablar, B., Garrett, K., Anderson, J.E. & Rudnicki, M.A. 1996. MyoD is required for myogenic stem cell function in adult skeletal muscle. Genes Dev 10, 1173-1183.
92. Meienberg, J., Rohrbach, M., Neuenschwander, S., Spanaus, K., Giunta, C., Alonso, S., Arnold, E., Henggeler, C., Regenass, S., Patrignani, A. et al. 2010. Hemizygous deletion of COL3A1, COL5A2, and MSTN causes a complex phenotype with aortic dissection: a lesson for and from true haploinsufficiency. Eur J Hum Genet 18, 1315-1321.
93. Mendler, L., Zador, E., Ver Heyen, M., Dux, L. & Wuytack, F. 2000. Myostatin levels in regenerating rat muscles and in myogenic cell cultures. J Muscle Res Cell Motil 21, 551-563.
94. Milan, G., Dalla Nora, E., Pilon, C., Pagano, C., Granzotto, M., Manco, M., Mingrone, G. & Vettor, R. 2004. Changes in muscle myostatin expression in obese subjects after weight loss. J Clin Endocrinol Metab 89, 2724-2727.
95. Mitch, W.E. & Goldberg, A.L. 1996. Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. N Engl J Med 335, 1897-1905.
96. Molina, P.E., McNurlan, M., Rathmacher, J., Lang, C.H., Zambell, K.L., Purcell, J., Bohm, R.P., Zhang, P., Bagby, G.J. & Nelson, S. 2006. Chronic alcohol accentuates nutritional, metabolic, and immune alterations during asymptomatic simian immunodeficiency virus infection. Alcohol Clin Exp Res 30, 2065-2078.
97. Mosher, D.S., Quignon, P., Bustamante, C.D., Sutter, N.B., Mellersh, C.S., Parker, H.G. & Ostrander, E.A. 2007. A mutation in the myostatin gene increases muscle mass and enhances racing performance in heterozygote dogs. PLoS Genet 3, e79.
98. Murphy, K.T., Cobani, V., Ryall, J.G., Ibebunjo, C. & Lynch, G.S. 2011. Acute antibody-directed myostatin inhibition attenuates disuse muscle atrophy and weakness in mice. J Appl Physiol 110, 1065-1072.
99. Nakatani, M., Takehara, Y., Sugino, H., Matsumoto, M., Hashimoto, O., Hasegawa, Y., Murakami, T., Uezumi, A., Takeda, S., Noji, S., Sunada, Y. & Tsuchida, K. 2008. Transgenic expression of a myostatin inhibitor derived from follistatin increases skeletal muscle mass and ameliorates dystrophic pathology in mdx mice. Faseb J 22, 477-487.
100. Nicholas, G., Thomas, M., Langley, B., Somers, W., Patel, K., Kemp, C.F., Sharma, M. & Kambadur, R. 2002. Titin-cap associates with, and regulates secretion of, Myostatin. J Cell Physiol 193, 120-131.
101. Nozaki, M., Li, Y., Zhu, J., Ambrosio, F., Uehara, K., Fu, F.H. & Huard, J. 2008. Improved muscle healing after contusion injury by the inhibitory effect of suramin on myostatin, a negative regulator of muscle growth. Am J Sports Med 36, 2354-2362.
102. Ohsawa, Y., Hagiwara, H., Nakatani, M., Yasue, A., Moriyama, K., Murakami, T., Tsuchida, K., Noji, S. & Sunada, Y. 2006. Muscular atrophy of caveolin-3-deficient mice is rescued by myostatin inhibition. J Clin Invest 116, 2924-2934.
103. Oldham, J.M., Osepchook, C.C., Jeanplong, F., Falconer, S.J., Matthews, K.G., Conaglen, J.V., Gerrard, D.F., Smith, H.K., Wilkins, R.J., Bass, J.J. & McMahon, C.D. 2009. The decrease in mature myostatin protein in male skeletal muscle is developmentally regulated by growth hormone. J Physiol 587, 669-677.
104. Peters, D., Barash, I.A., Burdi, M., Yuan, P.S., Mathew, L., Friden, J. & Lieber, R.L. 2003. Asynchronous functional, cellular and transcriptional changes after a bout of eccentric exercise in the rat. J Physiol 553, 947-957.
105. Prontera, P., Bernardini, L., Stangoni, G., Capalbo, A., Rogaia, D., Ardisia, C., Novelli, A., Dallapiccola, B. & Donti, E. 2009. 2q31.2q32.3 deletion syndrome: report of an adult patient. Am J Med Genet A 149A, 706-712.
106. Ratkevicius, A., Joyson, A., Selmer, I., Dhanani, T., Grierson, C., Tommasi, A.M., Devries, A., Rauchhaus, P., Crowther, D., Alesci, S. et al.2011. Serum concentrations of myostatin and myostatin-interacting proteins do not differ between Young and Sarcopenic elderly men. J Gerontol A Biol Sci Med Sci 66A, 620-626.
107. Reardon, K.A., Davis, J., Kapsa, R.M., Choong, P. & Byrne, E. 2001. Myostatin, insulin-like growth factor-1, and leukemia inhibitory factor mRNAs are upregulated in chronic human disuse muscle atrophy. Muscle Nerve 24, 893-899.
108. Rebbapragada, A., Benchabane, H., Wrana, J.L., Celeste, A.J. & Attisano, L. 2003. Myostatin signals through a transforming growth factor beta-like signaling pathway to block adipogenesis. Mol Cell Biol 23, 7230-7242.
109. Rios, R., Carneiro, I., Arce, V.M. & Devesa, J. 2002. Myostatin is an inhibitor of myogenic differentiation. Am J Physiol Cell Physiol 282, C993-C999.
110. Rodgers, B.D. & Garikipati, D.K. 2008. Clinical, agricultural, and evolutionary biology of myostatin: a comparative review. Endocr Rev 29, 513-534.
111. Roth, S.M., Martel, G.F., Ferrell, R.E., Metter, E.J., Hurley, B.F. & Rogers, M.A. 2003. Myostatin gene expression is reduced in humans with heavy-resistance strength training: a brief communication. Exp Biol Med (Maywood) 228, 706-709.
112. Salehian, B., Mahabadi, V., Bilas, J., Taylor, W.E. & Ma, K. 2006. The effect of glutamine on prevention of glucocorticoid-induced skeletal muscle atrophy is associated with myostatin suppression. Metabolism 55, 1239-1247.
113. Schuelke, M., Wagner, K.R., Stolz, L.E., Hubner, C., Riebel, T., Komen, W., Braun, T., Tobin, J.F. & Lee, S.J. 2004. Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med 350, 2682-2688.
114. Schulte, J.N. & Yarasheski, K.E. 2001. Effects of resistance training on the rate of muscle protein synthesis in frail elderly people. Int J Sport Nutr Exerc Metab 11(Suppl), S111-S118.
115. Seibert, M.J., Xue, Q.L., Fried, L.P. & Walston, J.D. 2001. Polymorphic variation in the human myostatin (GDF-8) gene and association with strength measures in the women's health and aging study II cohort. J Am Geriatr Soc 49, 1093-1096.
116. Sharma, M., Kambadur, R., Matthews, K.G., Somers, W.G., Devlin, G.P., Conaglen, J.V., Fowke, P.J. & Bass, J.J. 1999. Myostatin, a transforming growth factor-beta superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarct. J Cell Physiol 180, 1-9.
117. Siriett, V., Salerno, M.S., Berry, C., Nicholas, G., Bower, R., Kambadur, R. & Sharma, M. 2007. Antagonism of myostatin enhances muscle regeneration during sarcopenia. Mol Ther 15, 1463-1470.
118. Southgate, R.J., Neill, B., Prelovsek, O., El-Osta, A., Kamei, Y., Miura, S., Ezaki, O., McLoughlin, T.J., Zhang, W., Unterman, T.G. & Febbraio, M.A. 2007. FOXO1 regulates the expression of 4E-BP1 and inhibits mTOR signaling in mammalian skeletal muscle. J Biol Chem 282, 21176-21186.
119. Steffen, B.T., Lees, S.J. & Booth, F.W. 2008. Anti-TNF treatment reduces rat skeletal muscle wasting in monocrotaline-induced cardiac cachexia. J Appl Physiol 105, 1950-1958.
120. Stolz, L.E., Li, D., Qadri, A., Jalenak, M., Klaman, L.D. & Tobin, J.F. 2008. Administration of myostatin does not alter fat mass in adult mice. Diabetes Obes Metab 10, 135-142.
121. Swallow, E.B., Reyes, D., Hopkinson, N.S., Man, W.D., Porcher, R., Cetti, E.J., Moore, A.J., Moxham, J. & Polkey, M.I. 2007. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax 62, 115-120.
122. Taylor, W.E., Bhasin, S., Artaza, J., Byhower, F., Azam, M., Willard, D.H., Kull F. C. Jr, & Gonzalez-Cadavid, N. 2001. Myostatin inhibits cell proliferation and protein synthesis in C2C12 muscle cells. Am J Physiol Endocrinol Metab 280, E221-E228.
123. Tessitore, L., Costelli, P. & Baccino, F.M. 1994. Pharmacological interference with tissue hypercatabolism in tumour-bearing rats. Biochem J 299(Pt 1), 71-78.
124. Thies, R.S., Chen, T., Davies, M.V., Tomkinson, K.N., Pearson, A.A., Shakey, Q.A. & Wolfman, N.M. 2001. GDF-8 propeptide binds to GDF-8 and antagonizes biological activity by inhibiting GDF-8 receptor binding. Growth Factors 18, 251-259.
125. Thomas, M., Langley, B., Berry, C., Sharma, M., Kirk, S., Bass, J. & Kambadur, R. 2000. Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation. J Biol Chem 275, 40235-40243.
126. Wagner, P.D. 2008. Possible mechanisms underlying the development of cachexia in COPD. Eur Respir J 31, 492-501.
127. Wagner, K.R., Fleckenstein, J.L., Amato, A.A., Barohn, R.J., Bushby, K., Escolar, D.M., Flanigan, K.M., Pestronk, A., Tawil, R., Wolfe, G.I. et al.2008. A phase I/II trial of MYO-029 in adult subjects with muscular dystrophy. Ann Neurol 63, 561-571.
128. Walker, K.S., Kambadur, R., Sharma, M. & Smith, H.K. 2004. Resistance training alters plasma myostatin but not IGF-1 in healthy men. Med Sci Sports Exerc 36, 787-793.
129. Weber, T.E., Small, B.C. & Bosworth, B.G. 2005. Lipopolysaccharide regulates myostatin and MyoD independently of an increase in plasma cortisol in channel catfish (Ictalurus punctatus). Domest Anim Endocrinol 28, 64-73.
130. Whittemore, L.A., Song, K., Li, X., Aghajanian, J., Davies, M., Girgenrath, S., Hill, J.J., Jalenak, M., Kelley, P., Knight, A. et al.2003. Inhibition of myostatin in adult mice increases skeletal muscle mass and strength. Biochem Biophys Res Commun 300, 965-971.
131. Willoughby, D.S. 2004a. Effects of an alleged myostatin-binding supplement and heavy resistance training on serum myostatin, muscle strength and mass, and body composition. Int J Sport Nutr Exerc Metab 14, 461-472.
132. Willoughby, D.S. 2004b. Effects of heavy resistance training on myostatin mRNA and protein expression. Med Sci Sports Exerc 36, 574-582.
133. Yamaguchi, A., Fujikawa, T., Shimada, S., Kanbayashi, I., Tateoka, M., Soya, H., Takeda, H., Morita, I., Matsubara, K. & Hirai, T. 2006. Muscle IGF-I Ea, MGF, and myostatin mRNA expressions after compensatory overload in hypophysectomized rats. Pflugers Arch 453, 203-210.
134. Yang, W., Zhang, Y., Li, Y., Wu, Z. & Zhu, D. 2007. Myostatin induces cyclin D1 degradation to cause cell cycle arrest through a phosphatidylinositol 3-kinase/AKT/GSK-3 beta pathway and is antagonized by insulin-like growth factor 1. J Biol Chem 282, 3799-3808.
135. Yarasheski, K.E., Bhasin, S., Sinha-Hikim, I., Pak-Loduca, J. & Gonzalez-Cadavid, N.F. 2002. Serum myostatin-immunoreactive protein is increased in 60-92 year old women and men with muscle wasting. J Nutr Health Aging 6, 343-348.
136. Zachwieja, J.J., Smith, S.R., Sinha-Hikim, I., Gonzalez-Cadavid, N. & Bhasin, S. 1999. Plasma myostatin-immunoreactive protein is increased after prolonged bed rest with low-dose T3 administration. J Gravit Physiol 6, 11-15.
137. Zhang, C., McFarlane, C., Lokireddy, S., Bonala, S., Ge, X., Masuda, S., Gluckman, P., Sharma, M. & Kambadur, R. 2011. Myostatin-deficient mice exhibit reduced insulin resistance through activating the AMP-activated protein kinase signalling pathway. Diabetologia 54, 1491-1501.
138. Zhao, B., Wall, R.J. & Yang, J. 2005. Transgenic expression of myostatin propeptide prevents diet-induced obesity and insulin resistance. Biochem Biophys Res Commun 337, 248-255.
139. Zhu, X., Topouzis, S., Liang, L.F. & Stotish, R.L. 2004. Myostatin signaling through Smad2, Smad3 and Smad4 is regulated by the inhibitory Smad7 by a negative feedback mechanism. Cytokine 26, 262-272.
140. Zimmers, T.A., Davies, M.V., Koniaris, L.G., Haynes, P., Esquela, A.F., Tomkinson, K.N., McPherron, A.C., Wolfman, N.M. & Lee, S.J. 2002. Induction of cachexia in mice by systemically administered myostatin. Science 296, 1486-1488.
141. Zurlo, F., Larson, K., Bogardus, C. & Ravussin, E. 1990. Skeletal muscle metabolism is a major determinant of resting energy expenditure. J Clin Investig 86, 1423-1427.